Codexis.
American protein engineering company
- Reports this week
- 0
- Active events
- 0
- Connections
- 40
What's happening
Earlier this month
-
Codexis advanced production with its partner/product Synthesis.Some support1 report1 development inside
-
Codexis has reached an agreement to explore stereo-defined fragment synthesis as part of its advanced production strategy.Some support1 report
-
Revvity and Codexis, both healthcare companies, are currently competing against each other for market share.Some support2 reports
One to three months ago
Gone quiet
No new reports in 90+ days-
Analyst reports are influencing market perception of the company Codexis, with MarketBeat aggregating consensus ratings and price targets.Some support3 reports
-
Codexis, led by CEO Stephen Dilly, has a complex shareholding structure involving Opaleye Management Inc. as the largest shareholder, alongside Casdin Capital, LLC and BlackRock, Inc.Speculative1 report
-
Steve del Cardayre previously held senior roles at Renewable Energy Group and Codexis.Some support1 report
-
Codexis, a biomedical and genetics company, underperformed the S&P 500 this year.Some support1 report
-
ATM facility supported a capital raise while Codexis advanced its path toward GMP-grade siRNA.Some support1 report
-
Codexis announced that it will attend the Cantor Global Healthcare Conference on August 28, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Codexis this week
News at the entities that move Codexis most-
Cantor Fitzgerald OperationalCantor Fitzgerald initiated stock coverage on AgomAB Therapeutics, and Director David Epstein acquired company stock.Moves Codexis
-
Jimenez StructuralICE pursued Jimenez while he attempted to reenter the U.S., and an ICE vehicle struck Roberto Parra Hernandez.Moves Codexis
-
SEC StructuralIntuit filed a Form 4 with the SEC regarding insider share sales on August 30, 2026.Moves Codexis
-
MarketBeat Mentioned togetherMarketBeat identifies Celsius Network as a stock to watch, noting that the company sells products across multiple continents, including Europe.Moves Codexis
Connections
The 8 strongest of 40, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
SEC Structural
Codexis operates under the regulatory oversight and filing requirements of the U.S. Securities and Exchange Commission.
-
Cantor Fitzgerald Operational
Cantor Fitzgerald provides financial services, including bookrunning and rating reports, for Codexis.
-
Revvity Operational
Both companies are actively competing for market share within the healthcare sector.
-
Stefan Lutz Structural
Stefan Lutz serves as the CSO detailing enzyme technology for siRNA manufacturing at Codexis.
-
Synthesis Operational
Codexis is functionally involved in the production process of Synthesis, enabling its manufacturing output.
-
Jimenez Structural
The company utilizes the infrastructure's core capabilities as part of its operational model.
-
MarketBeat Mentioned together
MarketBeat aggregates consensus ratings and price targets for companies like Codexis.
-
Redwood City Shared context
Codexis is headquartered in Redwood City.
History
Events by the month they beganSeptember 2026
2 eventsAugust 2026
2 eventsJuly 2026
2 eventsShow 1 earlier month
June 2026
5 events- Codexis, led by CEO Stephen Dilly, has a complex shareholding structure involving Opaleye Management Inc. as the largest shareholder, alongside Casdin Capital, LLC and BlackRock, Inc.
- Steve del Cardayre previously held senior roles at Renewable Energy Group and Codexis.
- Codexis, a biomedical and genetics company, underperformed the S&P 500 this year.
- ATM facility supported a capital raise while Codexis advanced its path toward GMP-grade siRNA.
- Codexis announced that it will attend the Cantor Global Healthcare Conference on August 28, 2025.